Reject this cynical view that the drug companies will punish consumers before they will restrain some of the excesses if we finally take back part of the monopoly powers that the Republicans gave to the pharmaceutical industry.
Share
More from Earl Blumenauer
But reauthorizing the programs without improving them is a missed opportunity.
I would like to start by commending the Biden-Harris administration for their leadership role in the recent extension of the WTO e-commerce moratorium.
These things aren't going to get enacted into law, they are not going to make a difference to the American people. It is a distraction, it is a sideshow.
I can speak confidently for House Democrats when I say we are firmly committed to reauthorization of AGOA and HOPE before their expiration next year.
Other voices in this conversation
